|
10 Sep 2025 |
SRF
|
Consensus Share Price Target
|
2934.00 |
3104.79 |
- |
5.82 |
hold
|
|
|
|
|
09 May 2024
|
SRF
|
Prabhudas Lilladhar
|
2934.00
|
2123.00
|
2291.35
(28.05%)
|
Target met |
Sell
|
|
|
|
|
09 May 2024
|
SRF
|
Sharekhan
|
2934.00
|
2592.00
|
2291.35
(28.05%)
|
Target met |
Buy
|
|
|
Revenue for the quarter of Rs. 3570 crore was down 7% y-o-y and up 17% q-o-q. Chemical/ Technical textiles/packaging films segments grew 30%/8%/2% q-o-q and -14%/2%/9% y-o-y. Growth was affected due to the weak external environment in specialty chemicals and fluorochemicals.
|
|
01 Feb 2024
|
SRF
|
IDBI Capital
|
2934.00
|
2770.00
|
2308.45
(27.10%)
|
Target met |
Buy
|
|
|
|
|
30 Nov 2023
|
SRF
|
IDBI Capital
|
2934.00
|
2913.00
|
2412.50
(21.62%)
|
|
Buy
|
|
|
|
|
31 Oct 2023
|
SRF
|
Edelweiss
|
2934.00
|
2530.00
|
2195.30
(33.65%)
|
Target met |
Buy
|
|
|
Weak H1, recovery expected in H2FY24
|
|
30 Oct 2023
|
SRF
|
Motilal Oswal
|
2934.00
|
2000.00
|
2181.40
(34.50%)
|
|
Neutral
|
|
|
|
|
30 Oct 2023
|
SRF
|
Prabhudas Lilladhar
|
2934.00
|
2156.00
|
2181.40
(34.50%)
|
Target met |
Hold
|
|
|
|
|
30 Oct 2023
|
SRF
|
ICICI Securities Limited
|
2934.00
|
2100.00
|
2181.40
(34.50%)
|
Target met |
Hold
|
|
|
SRF’s Q2FY24 print for its chemical business (EBIT down 32.8% YoY) was below our expectations – hurt by lower sales in ref-gas and weakness in specialty sales from destocking. Despite this, SRF expects some growth in specialty chemicals revenue for FY24 and anticipates revival in ref-gas revenue in H2FY24E, as it has started to contract volumes in US for CY24 HFC quota.
|
|
26 Jul 2023
|
SRF
|
Edelweiss
|
2934.00
|
2570.00
|
2144.30
(36.83%)
|
Target met |
Buy
|
|
|
Weak earnings; recovery expected in H2FY24
|
|
26 Jul 2023
|
SRF
|
IDBI Capital
|
2934.00
|
2913.00
|
2144.30
(36.83%)
|
|
Buy
|
|
|
|